Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival

por Majchrzak-Celińska, Aleksandra, Słocińska, Marta, Barciszewska, Anna-Maria, Nowak, Stanisław, Baer-Dubowska, Wanda
Publicado 2015